Mencaine — Class II drug recall D-1279-2020
Ongoing recall by Wuhan Bingbing Pharmaceutical Co., Ltd., reported 2020-06-03, distributed nationwide. CGMP Deviations: due to the loss of product manufacturing records and retain product samples, there is no assu
| Recall number | D-1279-2020 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Ongoing |
| Voluntary or mandated | Voluntary |
| Recalling firm | Wuhan Bingbing Pharmaceutical Co., Ltd., Wuhan, N/A, China |
| Recall initiated | 2020-05-19 |
| Classified | 2020-05-28 |
| Reported by FDA | 2020-06-03 |
| Distributed | Nationwide (US) |
| Quantity | 1,800 pouches |
| Reason classes | labeling, cgmp |
| NDC | 53225-1090-01 |
| Lot numbers | 170731, 180504, 2020.07, 2021.05 |
Product
Mencaine (lidocaine 4.5%, menthol 5%) Patch, 1 patch per pouch, Manufactured For: Terrain Pharmaceuticals, Reno, NV 89501; NDC 53225-1090-1.
Reason for recall
CGMP Deviations: due to the loss of product manufacturing records and retain product samples, there is no assurance that the product will remain within specification through the labeled expiration date.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1279-2020. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.